Form 4: Achieve Life Sciences CFO Mark Oki Reports Stock Purchase
SEC Filing Form 4
Chief Financial Officer of Achieve Life Sciences, Mark Oki, reports the purchase of 10,000 shares of common stock.
Summary
- On March 17, 2025, Mark Oki, the Chief Financial Officer of Achieve Life Sciences, purchased 10,000 shares of the company's common stock.
- The purchase was made at a weighted average price of $2.8887 per share.
- Following the transaction, Mr. Oki directly owns 10,000 shares of Achieve Life Sciences.
- The transaction was filed on March 19, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. An insider purchase is generally viewed as a positive sign, but the size of the purchase is relatively small.
Positives
- The CFO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company executives and their confidence in the company's stock.
Stakeholder Impact
- Shareholders may view the CFO's stock purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of transaction: Mark Oki purchased 10,000 shares of common stock. |
| 03/19/2025 | Date of filing: Form 4 was filed. |
Keywords
ACHV, Achieve Life Sciences, Mark Oki, CFO, Form 4, Stock Purchase, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.